The Patent Finder

Boston Biomedical, Inc.

Also on record
Records under this name other than the patents Boston Biomedical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Boston Biomedical, Inc.

PatentTitleStatus Expires Confidence
US 8,710,057Imidazo[1,2-b]pyridazine and Pyrazolo[1,5-a]pyrimidine Derivatives and Their Use as Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,750,007Imidazo[1,2-beta]pyridazine and PYRAZOLO[1,5-Alpha]PYRIMIDINE Derivatives and Their Use as Protein Kinase Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,481,884Enabling the use of long dsRNA for gene targeting in mammalian and other selected animal cells
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,927,376Compositions of Asymmetric Interfering RNA and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,015,195Compositions of Asymmetric Interfering RNA and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 12,344,840Compositions of Asymmetric Interfering RNA and Uses Thereof
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,328,345Compositions of Asymmetric Interfering RNA and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,416,132Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,047,093Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,392,392Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 65 patents shown.
Pro members see all 65.
Pro members: see all 65 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited